Accordingly, we observed that DTA-1 treatment led to a partial depletion of Tregs in all lymphoid organs including pLN (Fig. 1d) where coincidently it induced a significant increase in the frequency and diversity of tumor-reactive Tregs (Fig. 5, upper right panel). The gene discussed is PLN; the disease is neoplasm.